AUKI Pharma ApS: Financial statements 2023
CVR: 43030493
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
AUKI Pharma ApS (CVR 43030493) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 5,390 and a net result of DKK -19,190 compared with DKK -36,750 the year before. The profit margin was -356%. Equity in the 2023 report amounted to DKK -15,931.
- Revenue
- DKK 5,390
- Gross Profit
- DKK 2,680
- Profit/Loss
- DKK -19,190
- Equity
- DKK -15,931
- Total Assets
- DKK 1,696,778
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 5 t. | 3 t. | -19 t. | -16 t. | - |
| 2022 | - | 57 t. | -37 t. | 3 t. | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
AUKI Pharma ApS has published its annual report for 2022. Gross profit came to DKK 57,015, and the net result was DKK -36,750.
About AUKI Pharma ApS
AUKI Pharma ApS was a Danish company of the type Anpartsselskab based in Juelsminde, founded in 2022. The company has been dissolved on 15 September 2025. The company was registered under the industry Fremstilling af andre fødevarer i.a.n.. The company has 1 employee (2022). In 2023, the company reported revenue of DKK 5,390 and a net result of DKK -19,190 compared with DKK -36,750 the year before. Equity in the 2023 report amounted to DKK -15,931.